Harnessing the N-Terminal Ectodomain of a T Cell Inhibitory Molecule, Btnl2, as a Therapeutic Modality In Ulcerative Colitis

dc.contributor.author	Hansda, Anita
dc.date.accessioned	2024-10-01T04:43:36Z
dc.date.available	2024-10-01T04:43:36Z
dc.date.issued	2024-07
dc.identifier.govdoc	NB18312
dc.identifier.uri	http://www.idr.iitkgp.ac.in/xmlui/handle/123456789/15312
dc.language.iso	en	en_US
dc.publisher	IIT Kharagpur	en_US
dc.subject	BTNL2 IgV1	en_US
dc.subject	Ulcerative Colitis	en_US
dc.subject	Peyer’s Patches	en_US
dc.subject	T Cell Inhibition	en_US
dc.subject	Structureguided Mutagenesis	en_US
dc.title	Harnessing the N-Terminal Ectodomain of a T Cell Inhibitory Molecule, Btnl2, as a Therapeutic Modality In Ulcerative Colitis	en_US
dc.type	Thesis	en_US